Europe Artificial Intelligence (AI) in Drug Discovery Market to 2032
Overview
The Europe Artificial Intelligence (AI) in Drug Discovery Market is expected to reach a 17,195.62 USD Million by 2032 and is projected to grow at a CAGR of 89.63% from 2025 to 2032.
Revenue, 2024 (USD Million)
505.84
Forecast, 2032 (USD Million)
17,195.62
CAGR, 2024 - 2032
89.63%
Report Coverage
Europe
Europe Artificial Intelligence (AI) in Drug Discovery Market 2018-2032 USD Million
Europe Artificial Intelligence (AI) in Drug Discovery Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 505.84 USD Million
- Projected Market Size (2032): 17,195.62 USD Million
- CAGR (2025-2032): 89.63%
Key Findings of Europe Artificial Intelligence (AI) in Drug Discovery Market
- The Europe Artificial Intelligence (AI) in Drug Discovery Market was valued at 505.84 USD Million in 2024.
- The Europe Artificial Intelligence (AI) in Drug Discovery Market is likely to grow at a CAGR of 89.63% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Small Molecule in Drug Type Segment accounted for the largest share of the market with a revenue of 371.53 USD Million
- The fastest growing segment Novel Drug Candidates in Application Segment grew Fastest with a CAGR of 107.63% during the forecast period from 2024 to 2032.
Europe Artificial Intelligence (AI) in Drug Discovery Market Scope
Europe Artificial Intelligence (AI) in Drug Discovery Market Segmentation & Scope
End Use
- Others
- Research Centres and Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
Indication
- Others
- Metabolic Diseases
- Cardiovascular Diseases
- Neurodegenerative Diseases
- Immuno-Oncology
Application
- Others
- Finding New Disease-Associated Targets and Pathways
- Understanding Disease Mechanisms
- Formation & Qualification of Hypotheses
- Finding Drug Targets of an Old Drug
- De Novo Drug Design
- Aggregating and Synthesizing Information
- Drug Monitoring
- Drug Optimisation and Re-purposing Pre-clinical testing and approval
- Novel Drug Candidates
Technology
- Others
- Natural Language Processing (NLP)
- Deep Learning
- Machine Learning (ML)
Offering
- Services
- Software
Drug Type
- Large Molecule
- Small Molecule
Europe Artificial Intelligence (AI) in Drug Discovery Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 505.84 USD Million |
| Market Value in 2032 | 17,195.62 USD Million |
| CAGR (2025-2032) | 89.63% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End Use,Indication,Application,Technology,Offering,Drug Type |
Regional Insights:
-
Leading Market (2024-2032): Europe, leading in terms of revenue 505.84 USD Million in 2024
- Key Country: U.K., leading in terms of revenue with value of 175.14 USD Million in 2024.
Segments and Scope
-
Europe Artificial Intelligence (AI) in Drug Discovery Market to 2032, By End Use
- Contract Research Organizations is the largest segment in Europe Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 204.93 USD Million in the year 2024.
- Contract Research Organizations is the Fastest growing segment in Europe Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 97.44 % in forecast period 2025-2032.
-
Europe Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Indication
- Immuno-Oncology is the largest segment in Europe Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 166.45 USD Million in the year 2024.
- Immuno-Oncology is the Fastest growing segment in Europe Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 95.19 % in forecast period 2025-2032.
-
Europe Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Application
- Novel Drug Candidates is the largest segment in Europe Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 134.36 USD Million in the year 2024.
- Novel Drug Candidates is the Fastest growing segment in Europe Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 107.63 % in forecast period 2025-2032.
-
Europe Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Technology
- Machine Learning (ML) is the largest segment in Europe Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 222.53 USD Million in the year 2024.
- Machine Learning (ML) is the Fastest growing segment in Europe Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 94.84 % in forecast period 2025-2032.
-
Europe Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Offering
- Software is the largest segment in Europe Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 308.78 USD Million in the year 2024.
- Services is the Fastest growing segment in Europe Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 87.81 % in forecast period 2025-2032.
-
Europe Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Drug Type
- Small Molecule is the largest segment in Europe Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 371.53 USD Million in the year 2024.
- Small Molecule is the Fastest growing segment in Europe Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 91.90 % in forecast period 2025-2032.
Europe Artificial Intelligence (AI) in Drug Discovery Market Company Share Analysis
Europe Artificial Intelligence (AI) in Drug Discovery Market Geographical Sales Distribution, 2018-2032 USD Million
Europe Artificial Intelligence (AI) in Drug Discovery Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Europe Artificial Intelligence (AI) in Drug Discovery Market is segmented based on Segmentation End Use,Indication,Application,Technology,Offering,Drug Type.
Europe Artificial Intelligence (AI) in Drug Discovery Market was valued at USD 505.84(Revenue in USD Million) in 2020.
Europe Artificial Intelligence (AI) in Drug Discovery Market is projected to grow at a CAGR of 89.63% during the forecast period of 2024 to 2032.
The Small Molecule segment is expected to dominate the Europe Artificial Intelligence (AI) in Drug Discovery Market, holding a largest market share of 371.53 USD Million in 2024
Europe Artificial Intelligence (AI) in Drug Discovery Market Scope
Europe Artificial Intelligence (AI) in Drug Discovery Market Segmentation & Scope
End Use
- Others
- Research Centres and Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
Indication
- Others
- Metabolic Diseases
- Cardiovascular Diseases
- Neurodegenerative Diseases
- Immuno-Oncology
Application
- Others
- Finding New Disease-Associated Targets and Pathways
- Understanding Disease Mechanisms
- Formation & Qualification of Hypotheses
- Finding Drug Targets of an Old Drug
- De Novo Drug Design
- Aggregating and Synthesizing Information
- Drug Monitoring
- Drug Optimisation and Re-purposing Pre-clinical testing and approval
- Novel Drug Candidates
Technology
- Others
- Natural Language Processing (NLP)
- Deep Learning
- Machine Learning (ML)
Offering
- Services
- Software
Drug Type
- Large Molecule
- Small Molecule
Frequently Asked Questions
The Europe Artificial Intelligence (AI) in Drug Discovery Market is segmented based on Segmentation End Use,Indication,Application,Technology,Offering,Drug Type.
Europe Artificial Intelligence (AI) in Drug Discovery Market was valued at USD 505.84(Revenue in USD Million) in 2020.
Europe Artificial Intelligence (AI) in Drug Discovery Market is projected to grow at a CAGR of 89.63% during the forecast period of 2024 to 2032.
The estimated market value of the Europe Artificial Intelligence (AI) in Drug Discovery Market for final year is USD 17,195.62 (USD Million).
Europe Artificial Intelligence (AI) in Drug Discovery Market Company Profiling
Frequently Asked Questions
The Europe Artificial Intelligence (AI) in Drug Discovery Market is segmented based on Segmentation End Use,Indication,Application,Technology,Offering,Drug Type.
Europe Artificial Intelligence (AI) in Drug Discovery Market was valued at USD 505.84(Revenue in USD Million) in 2020.
Europe Artificial Intelligence (AI) in Drug Discovery Market is projected to grow at a CAGR of 89.63% during the forecast period of 2024 to 2032.
The estimated market value of the Europe Artificial Intelligence (AI) in Drug Discovery Market for final year is USD 17,195.62 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.